Flecainide contraindications: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Flecainide}} {{CMG}}; {{AE}} {{SS}} ==Contraindications== Flecainide acetate is contraindicated in patients with pre-existing second- or third-degree AV block, o..." |
No edit summary |
||
| Line 10: | Line 10: | ||
{| | {| | ||
|[[File:Flecainide01.jpg|thumb|800px]] | |[[File:Flecainide01.jpg|thumb|800px]] | ||
|}<ref name="dailymed.nlm.nih.gov">{{ | |}<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = FLECAINIDE ACETATE TABLET [APOTEX CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72595783-e6a0-6b7a-f428-9ca03d707794#nlm34084-4 | publisher = | date = | accessdate = 11 March 2014 }}</ref> | ||
==References== | ==References== | ||
Revision as of 17:32, 11 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Contraindications
Flecainide acetate is contraindicated in patients with pre-existing second- or third-degree AV block, or with right bundle branch block when associated with a left hemiblock (bifascicular block), unless a pacemaker is present to sustain the cardiac rhythm should complete heart block occur. Flecainide acetate is also contraindicated in the presence of cardiogenic shock or known hypersensitivity to the drug.
 |
References
- ↑ "FLECAINIDE ACETATE TABLET [APOTEX CORP.]". Retrieved 11 March 2014.